Robert Peach
Director/Board Member at AMPLIA THERAPEUTICS LIMITED
Profile
Robert J.
Peach was the founder of Apoptos, Inc. (founded in 2007) and Receptos LLC (founded in 2009) where he held the titles of Vice President-Biology and Chief Scientific Officer, respectively.
Currently, he is an Independent Non-Executive Director at AdAlta Ltd.
(since 2016) and Amplia Therapeutics Ltd.
(since 2015).
Previously, he worked as a Senior Director-Oncology Discovery at Biogen, Inc. (2005-2007), Director at Avalia Immunotherapies Ltd., and Principal at Bristol Myers Squibb Co. (1991-2000).
Dr. Peach holds a doctorate from the University of Otago and undergraduate and graduate degrees from the University of Canterbury.
Robert Peach active positions
| Companies | Position | Start |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Director/Board Member | 2015-09-01 |
| ADALTA LIMITED | Director/Board Member | 2016-11-13 |
Former positions of Robert Peach
| Companies | Position | End |
|---|---|---|
| RECEPTOS INC | Founder | 2015-08-26 |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA | Founder | 2009-04-30 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Avalia Immunotherapies Ltd.
 Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Avalia Immunotherapies Ltd. develops immunotherapies that support the treatment of cancer. The company is headquartered in Lower Hutt, New Zealand. | Director/Board Member | - |
Training of Robert Peach
| University of Otago | Doctorate Degree |
| University of Canterbury | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOGEN INC. | Health Technology |
| ADALTA LIMITED | Health Technology |
| AMPLIA THERAPEUTICS LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
Avalia Immunotherapies Ltd.
Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Avalia Immunotherapies Ltd. develops immunotherapies that support the treatment of cancer. The company is headquartered in Lower Hutt, New Zealand. | Health Services |
- Stock Market
- Insiders
- Robert Peach
